Global COVID-19 Vaccines & Therapeutics Market Growth (Status and Outlook) 2023-2029

March 2023 | 75 pages | ID: G5ADCA6B377DEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global COVID-19 Vaccines & Therapeutics market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Vaccines & Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by product type:
  • COVID-19 Vaccines
  • COVID-19 Therapeutics
Segmentation by Application:
  • Children
  • Adult
This report also splits the market by region:
  • United States
  • China
  • Europe
  • Other regions:
    • Japan
    • South Korea
    • Southeast Asia
    • Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Pfizer
  • Moderna Therapeutics
  • AstraZeneca
  • Janssen
  • Novavax
  • Gilead Sciences
  • Eli Lilly and Company
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COVID-19 Vaccines & Therapeutics Market Size 2024-2029
  2.1.2 COVID-19 Vaccines & Therapeutics Market Size CAGR by Region
2.2 COVID-19 Vaccines & Therapeutics Segment by Type
  2.2.1 COVID-19 Vaccines
  2.2.2 COVID-19 Therapeutics
2.3 COVID-19 Vaccines & Therapeutics Market Size by Type
  2.3.1 Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2024-2029)
  2.3.2 Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Type (2024-2029)
2.4 COVID-19 Vaccines & Therapeutics Segment by Application
  2.4.1 Children
  2.4.2 Adult
2.5 COVID-19 Vaccines & Therapeutics Market Size by Application
  2.5.1 Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2024-2029)
  2.5.2 Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate by Application (2024-2029)

3 COVID-19 VACCINES & THERAPEUTICS KEY PLAYERS

3.1 Date of Key Players Enter into COVID-19 Vaccines & Therapeutics
3.2 Key Players COVID-19 Vaccines & Therapeutics Product Offered
3.3 Key Players COVID-19 Vaccines & Therapeutics Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 Vaccines & Therapeutics Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 COVID-19 VACCINES & THERAPEUTICS BY REGIONS

4.1 COVID-19 Vaccines & Therapeutics Market Size by Regions (2024-2029)
4.2 United States COVID-19 Vaccines & Therapeutics Market Size Growth (2024-2029)
4.3 China COVID-19 Vaccines & Therapeutics Market Size Growth (2024-2029)
4.4 Europe COVID-19 Vaccines & Therapeutics Market Size Growth (2024-2029)
4.5 Rest of World COVID-19 Vaccines & Therapeutics Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029)
5.2 United States COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029)
6.2 Europe COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029)

7 CHINA

7.1 China COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029)
7.2 China COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029)
8.2 Rest of World COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN COVID-19 VACCINES & THERAPEUTICS

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Details
  11.1.2 Pfizer COVID-19 Vaccines & Therapeutics Product Offered
  11.1.3 Pfizer COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer News
11.2 Moderna Therapeutics
  11.2.1 Moderna Therapeutics Company Details
  11.2.2 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Product Offered
  11.2.3 Moderna Therapeutics COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
  11.2.4 Moderna Therapeutics Main Business Overview
  11.2.5 Moderna Therapeutics News
11.3 AstraZeneca
  11.3.1 AstraZeneca Company Details
  11.3.2 AstraZeneca COVID-19 Vaccines & Therapeutics Product Offered
  11.3.3 AstraZeneca COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
  11.3.4 AstraZeneca Main Business Overview
  11.3.5 AstraZeneca News
11.4 Janssen
  11.4.1 Janssen Company Details
  11.4.2 Janssen COVID-19 Vaccines & Therapeutics Product Offered
  11.4.3 Janssen COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
  11.4.4 Janssen Main Business Overview
  11.4.5 Janssen News
11.5 Novavax
  11.5.1 Novavax Company Details
  11.5.2 Novavax COVID-19 Vaccines & Therapeutics Product Offered
  11.5.3 Novavax COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
  11.5.4 Novavax Main Business Overview
  11.5.5 Novavax News
11.6 Gilead Sciences
  11.6.1 Gilead Sciences Company Details
  11.6.2 Gilead Sciences COVID-19 Vaccines & Therapeutics Product Offered
  11.6.3 Gilead Sciences COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
  11.6.4 Gilead Sciences Main Business Overview
  11.6.5 Gilead Sciences News
11.7 Eli Lilly and Company
  11.7.1 Eli Lilly and Company Company Details
  11.7.2 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Product Offered
  11.7.3 Eli Lilly and Company COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
  11.7.4 Eli Lilly and Company Main Business Overview
  11.7.5 Eli Lilly and Company News
...

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. COVID-19 Vaccines & Therapeutics Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of COVID-19 Vaccines
Table 3. Major Players of COVID-19 Therapeutics
Table 4. Global COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029) ($ Millions)
Table 5. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2024-2029)
Table 6. Global COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029) ($ Millions)
Table 7. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2024-2029)
Table 8. Date of Global Key Players Enter into COVID-19 Vaccines & Therapeutics Market
Table 9. Global Key Players COVID-19 Vaccines & Therapeutics Product Offered
Table 10. Key Players COVID-19 Vaccines & Therapeutics Funding/Investment ($ Millions)
Table 11. Funding/Investment by Regions
Table 12. Funding/Investment by End Industry
Table 13. Key Players COVID-19 Vaccines & Therapeutics Valuation & Market Capitalization ($ Millions)
Table 14. Key Players Mergers & Acquisitions, Expansion Plans
Table 15. COVID-19 Vaccines & Therapeutics New Product/Technology Launches
Table 16. COVID-19 Vaccines & Therapeutics Industry Partnerships, Agreements, and Collaborations
Table 17. COVID-19 Vaccines & Therapeutics Industry Mergers and Acquisitions
Table 18. Global COVID-19 Vaccines & Therapeutics Market Size by Regions 2024-2029 ($ Millions)
Table 19. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Regions 2024-2029
Table 20. United States COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029) ($ Millions)
Table 21. United States COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2024-2029)
Table 22. United States COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029) ($ Millions)
Table 23. United States COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2024-2029)
Table 24. Europe COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029) ($ Millions)
Table 25. Europe COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2024-2029)
Table 26. Europe COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029) ($ Millions)
Table 27. Europe COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2024-2029)
Table 28. China COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029) ($ Millions)
Table 29. China COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2024-2029)
Table 30. China COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029) ($ Millions)
Table 31. China COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2024-2029)
Table 32. Rest of World COVID-19 Vaccines & Therapeutics Market Size by Type (2024-2029) ($ Millions)
Table 33. Rest of World COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2024-2029)
Table 34. Rest of World COVID-19 Vaccines & Therapeutics Market Size by Application (2024-2029) ($ Millions)
Table 35. Rest of World COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2024-2029)
Table 36. Key Market Drivers & Growth Opportunities of COVID-19 Vaccines & Therapeutics
Table 37. Key Market Challenges & Risks of COVID-19 Vaccines & Therapeutics
Table 38. Key Industry Trends of COVID-19 Vaccines & Therapeutics
Table 39. Company A Company Details
Table 40. Companies Invested by Company A
Table 41. Company A Key Development and Market Layout
Table 42. Company B Company Details
Table 43. Companies Invested by Company B
Table 44. Company B Key Development and Market Layout
Table 45. Company C Company Details
Table 46. Companies Invested by Company C
Table 47. Company C Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 52. Pfizer COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
Table 53. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. Moderna Therapeutics COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
Table 55. AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. AstraZeneca COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
Table 57. Janssen Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Janssen COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
Table 59. Novavax Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Novavax COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
Table 61. Gilead Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Gilead Sciences COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)
Table 63. Eli Lilly and Company Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Eli Lilly and Company COVID-19 Vaccines & Therapeutics Market Size (2023 VS 2029)

LIST OF FIGURES

Figure 1. Picture of COVID-19 Vaccines & Therapeutics
Figure 2. COVID-19 Vaccines & Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COVID-19 Vaccines & Therapeutics Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. COVID-19 Vaccines & Therapeutics Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Type (2024-2029)
Figure 9. Global COVID-19 Vaccines Market Size Growth Rate
Figure 10. Global COVID-19 Therapeutics Market Size Growth Rate
Figure 11. COVID-19 Vaccines & Therapeutics in Children
Figure 12. Global COVID-19 Vaccines & Therapeutics Market: Children (2024-2029) ($ Millions)
Figure 13. COVID-19 Vaccines & Therapeutics in Adult
Figure 14. Global COVID-19 Vaccines & Therapeutics Market: Adult (2024-2029) ($ Millions)
Figure 15. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Application (2024-2029)
Figure 16. Global COVID-19 Vaccines & Therapeutics Market Size in Children Growth Rate
Figure 17. Global COVID-19 Vaccines & Therapeutics Market Size in Adult Growth Rate
Figure 18. Funding/Investment
Figure 19. Global COVID-19 Vaccines & Therapeutics Market Size Market Share by Regions 2024-2029
Figure 20. United States COVID-19 Vaccines & Therapeutics Market Size 2024-2029 ($ Millions)
Figure 21. China COVID-19 Vaccines & Therapeutics Market Size 2024-2029 ($ Millions)
Figure 22. Europe COVID-19 Vaccines & Therapeutics Market Size 2024-2029 ($ Millions)
Figure 23. Rest of World COVID-19 Vaccines & Therapeutics Market Size 2024-2029 ($ Millions)
Figure 24. United States COVID-19 Vaccines & Therapeutics Consumption Market Share by Type in 2029
Figure 25. United States COVID-19 Vaccines & Therapeutics Market Size Market Share by Application in 2029
Figure 26. China COVID-19 Vaccines & Therapeutics Consumption Market Share by Type in 2029
Figure 27. China COVID-19 Vaccines & Therapeutics Market Size Market Share by Application in 2029
Figure 28. Europe COVID-19 Vaccines & Therapeutics Consumption Market Share by Type in 2029
Figure 29. Europe COVID-19 Vaccines & Therapeutics Market Size Market Share by Application in 2029
Figure 30. Rest of World COVID-19 Vaccines & Therapeutics Consumption Market Share by Type in 2029
Figure 31. Rest of World COVID-19 Vaccines & Therapeutics Market Size Market Share by Application in 2029


More Publications